ArticleActa neurologica Belgica2026
Comparative effectiveness and safety of rituximab versus ocrelizumab in relapsing-remitting multiple sclerosis: a real-world experience from Iran.
Fatemeh Meshkini et al.PubMed ↗Publisher ↗
No numbers read from the abstract.